Virzì Grazia Maria, Clementi Anna, Brocca Alessandra, de Cal Massimo, Marcante Stefano, Ronco Claudio
Department of Nephrology, Dialysis and Transplantation, St Bortolo Hospital, Vicenza, Italy.
Kidney Blood Press Res. 2016;41(6):1008-1015. doi: 10.1159/000452602. Epub 2016 Dec 23.
BACKGROUND/AIMS: Cardiorenal Syndrome Type 5 (CRS Type 5) is characterized by concomitant cardiac and renal dysfunction in the setting of different systemic disorders, such as sepsis. In this study, we investigated the possible relationship between endotoxin levels, renal cell death and inflammation in septic patients with CRS Type 5. METHODS: We enrolled 11 patients with CRS Type 5. CRS Type 5 was defined according to the current classification system. AKI was defined by Acute Kidney Injury Network (AKIN) criteria. Acute cardiac dysfunction was documented by echocardiography as acute left and/or right ventricular dysfunction leading to decreased ejection fraction. Endotoxin activity was measured by the Endotoxin Activity Assay (EAA). Plasma from CRS Type 5 patients was incubated with renal tubular cells (RTCs) and cell death levels were evaluated. Plasma cytokines levels were measured as well. RESULTS: Accordingly to EAA levels, patients were divided into two groups: 45.4% of patients had low endotoxin activity level (negative EAA), while 54.5% of patients showed high endotoxin activity (positive EAA). RTCs incubated with plasma from EAA positive patients showed significantly higher apoptosis levels and higher caspase-3 activation compared to cells incubated with plasma from EAA negative patients, and a significant positive correlation was observed between EAA levels and RTC apoptosis levels. Furthermore, IL-6 and IFN-γ levels were significantly higher in CRS Type 5 patients with positive EAA. CONCLUSION: Our data suggest a possible relationship between endotoxin levels and renal cell death in septic patients with CRS Type 5. Furthermore, this study highlights the presence of renal apoptosis, the immune deregulation and the strong inflammation in CRS Type 5 patients, especially in those with high endotoxin activity.
背景/目的:5型心肾综合征(CRS 5型)的特征是在不同的全身性疾病(如脓毒症)背景下,心脏和肾脏功能同时出现障碍。在本研究中,我们调查了5型CRS脓毒症患者内毒素水平、肾细胞死亡与炎症之间的可能关系。 方法:我们纳入了11例5型CRS患者。5型CRS根据当前分类系统进行定义。急性肾损伤(AKI)根据急性肾损伤网络(AKIN)标准进行定义。急性心脏功能障碍通过超声心动图记录为导致射血分数降低的急性左心室和/或右心室功能障碍。内毒素活性通过内毒素活性测定(EAA)进行测量。将5型CRS患者的血浆与肾小管细胞(RTCs)一起孵育,并评估细胞死亡水平。同时测量血浆细胞因子水平。 结果:根据EAA水平,患者分为两组:45.4%的患者内毒素活性水平低(EAA阴性),而54.5%的患者内毒素活性高(EAA阳性)。与用EAA阴性患者血浆孵育的细胞相比,用EAA阳性患者血浆孵育的RTCs显示出明显更高的凋亡水平和更高的半胱天冬酶-3激活,并且观察到EAA水平与RTC凋亡水平之间存在显著正相关。此外,EAA阳性的5型CRS患者中白细胞介素-6和干扰素-γ水平显著更高。 结论:我们的数据表明5型CRS脓毒症患者内毒素水平与肾细胞死亡之间可能存在关系。此外,本研究突出了5型CRS患者中肾细胞凋亡、免疫失调和强烈炎症的存在,尤其是在内毒素活性高的患者中。
Kidney Blood Press Res. 2016
Anal Cell Pathol (Amst). 2015
Blood Purif. 2017-11-22
Cardiorenal Med. 2018-5-30
G Ital Nefrol. 2017-3
Cardiorenal Med. 2021
Diagnostics (Basel). 2022-12-27
Cancer Diagn Progn. 2022-3-3
BMC Nephrol. 2018-10-23
ESC Heart Fail. 2018-7-17